CAS: 1498-96-0; 4-Butoxybenzoic Acid

相似化合物

5736-88-9 6214-45-5 5438-19-7

上下游产品

CAS号5365-43-5 ethyl 4-butoxyb... | CAS号4906-25-6 4-正丁氧苯甲酸甲酯 | CAS号109-65-9 正溴丁烷 | CAS号99-96-7 4-羟基苯甲酸 | CAS号5736-88-9 4-丁氧基苯甲醛 | CAS号99-76-3 尼泊金甲酯 | CAS号120-47-8 尼泊金乙酯 | CAS号123-08-0 4-羟基苯甲醛; 对羟基苯甲醛 | CAS号542-69-8 碘代正丁烷 | CAS号16782-08-4 四羟基苯甲酸一钾 | CAS号4906-25-6 4-正丁氧苯甲酸甲酯 | CAS号33863-86-4 4-丁氧基苯甲酰氯 | CAS号64328-61-6 4-丁氧基苯甲酸肼 | CAS号131355-99-2 but-3-enyl 2,5-... | CAS号33905-62-3 4-丁氧苯甲酸-4-羟基苯酯 | CAS号28439-86-3 4-正丁氧基苯酚异氰酸酯 | CAS号67032-38-6 [2,2-dimethyl-3... | CAS号90233-54-8 (4-ethoxycarbon... | CAS号53146-63-7 4-丁基苯甲酸-4-乙氧基苯酯 | CAS号58600-97-8 (4-methylphenyl...

📜4-丁氧基苯甲醛置于氢氧化钾,Silver Nitrate体系中,用 乙醇 用作溶剂,化学反应 2.0H,反应生成4-丁氧基苯甲酸
参考文献:雷莫拉宁新半合成衍生物的合成和初步生物学表征.
标题:雷莫拉宁新半合成衍生物的合成和初步生物学表征.
摘要:雷莫拉宁是一种糖脂肽肽抗生素,对革兰氏阳性细菌(包括耐万古霉素的肠球菌)具有活性.雷莫拉宁通过不同于糖肽的机制抑制细菌细胞壁的生物合成,因此对这些抗生素没有交叉耐药性.到目前为止,由于静脉内注射时局部耐受性低,因此一直无法阻止雷莫拉汀的全身使用.为了克服这个问题,选择性去除了拉莫普林的脂肪酸侧链,并用各种不同的羧酸代替.许多新的雷莫拉宁衍生物显示出与天然前体相似的抗微生物活性,并具有明显改善的局部耐受性.
Doi:10.1021/jm070042Z

专利信息

专利号:US-9453037-B2
优先权日:2011-07-28
标 题 :Methylphenidate-prodrugs, processes of making and using the same
发明人：GUENTHER SVEN; CHI GUOCHEN; BERA BINDU; MICKLE TRAVIS; BERA SANJIB
权利人:KEMPHARM INC; KEMPHARM INC
摘要:The present technology is directed to prodrugs and compositions for the treatment of various diseases and/or disorders comprising methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof. In some embodiments, the conjugates further include at least one linker. The present technology also relates to the synthesis of methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof or combinations thereof.

专利号:US-9217012-B2
优先权日:2009-04-08
标题 :Inhibitors of protein tyrosine phosphatases
发明人：ZHANG ZHONG-YIN; ZHANG SHENG
权利人:ZHANG ZHONG-YIN; ZHANG SHENG; UNIV INDIANA RES & TECH CORP
摘要:Disclosed herein are compounds that selectively inhibit members of the PTP family of enzymes. Synthesized compounds demonstrated selective inhibition of TC-PTP. Also provided are methods of using the compounds and formulations containing the compounds. Also described is a fluorescence-tagged combinatorial library synthesis and screening method. And methods of using these compounds to effect enzyme activity both in cells and in vitro as well as method of using these compounds to treat diseases in human and animals.

专利号:WO-2009131274-A1
优先权日:2008-04-23
标 题:Synthesis of photoinitiator free reactive mesogens based on triphenylene

专利号:US-2008176857-A1
优先权日:2005-03-25
标题 :4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
权利人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: n n n n n n n n n n wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2 , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:US-2011152210-A1
优先权日:2009-12-18
标题 :Polyphenol compounds for inhibiting proteasome and uses thereof
发明人：CHAN TAK-HANG; DOU Q PING
权利人:UNIV MCGILL; UNIV HONG KONG POLYTECHNIC; UNIV WAYNE STATE
摘要:Synthetic polyphenolic compounds of formula (I), their modes of synthesis, and pharmaceutical compositions thereof are provided herein. Use of the compounds and compositions described herein for inhibiting proteasomal activity and for treating cancer is also provided.

专利号:US-2014378541-A1
优先权日:2011-06-16
标题 :Synthetic Epigallocatechin Gallate (EGCG) Analogs
发明人：CHAN TAK-HANG; PAMU SREEDHAR; DOU QING PING; CHEN DI
权利人:CHAN TAK-HANG; PAMU SREEDHAR; DOU QING PING; CHEN DI; UNIV WAYNE STATE; UNIV MCGILL; UNIV HONG KONG POLYTECHNIC
摘要:Synthetic polyphenolic compounds of formula (I), their modes of synthesis, and pharmaceutical compositions thereof are provided herein. Use of the compounds and compositions described herein for treating cancer and for treating metabolic disorders is also provided.